| scholarly article | Q13442814 |
| P50 | author | Somchai Chutipongtanate | Q41653525 |
| Prasert Auewarakul | Q43156881 | ||
| P2093 | author name string | Pilaipan Puthavathana | |
| Pathawut Wacharapornin | |||
| Sirawat Srichatrapimuk | |||
| P2860 | cites work | Structural organization of authentic, mature HIV-1 virions and cores | Q39744816 |
| Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation | Q39871663 | ||
| Mechanisms of virus uncoating | Q40742902 | ||
| Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. | Q41629680 | ||
| HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection | Q45345418 | ||
| Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1. | Q45789234 | ||
| Pleconaril, a novel antipicornaviral agent | Q28182006 | ||
| Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 | ||
| Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus | Q30196123 | ||
| Viral ion channels: molecular modeling and simulation | Q33536851 | ||
| Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells | Q33783211 | ||
| Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag). | Q33807166 | ||
| Picornavirus uncoating | Q33960512 | ||
| Highlights in the development of new antiviral agents | Q33961840 | ||
| Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication | Q34364648 | ||
| HIV-1 assembly and maturation | Q35787330 | ||
| Highly purified CD25- resting T cells cannot be infected de novo with HIV-1 | Q35996665 | ||
| Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes | Q36368207 | ||
| Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1 | Q37292229 | ||
| Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. | Q39588178 | ||
| Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex | Q39736736 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 93-101 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Uncoating of HIV-1 requires cellular activation. | |
| P478 | volume | 337 |
| Q36150032 | A Novel Entry/Uncoating Assay Reveals the Presence of at Least Two Species of Viral Capsids During Synchronized HIV-1 Infection |
| Q39443387 | A whole genome screen for HIV restriction factors |
| Q35122165 | Blocking premature reverse transcription fails to rescue the HIV-1 nucleocapsid-mutant replication defect |
| Q36424184 | Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro |
| Q39914308 | Cell-free assays for HIV-1 uncoating |
| Q33285871 | Centrosomal latency of incoming foamy viruses in resting cells |
| Q40082670 | Centrosomal pre-integration latency of HIV-1 in quiescent cells |
| Q37256671 | Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection. |
| Q37714016 | Contribution of PDZD8 to stabilization of the human immunodeficiency virus type 1 capsid |
| Q59330226 | Cyclophilin A as a target in the treatment of cytomegalovirus infections |
| Q41674214 | Cytoplasmic dynein promotes HIV-1 uncoating |
| Q37849655 | Early events of HIV-1 infection: can signaling be the next therapeutic target? |
| Q33304219 | Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells |
| Q24548932 | Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains |
| Q26995784 | HIV restriction in quiescent CD4⁺ T cells |
| Q52339973 | HIV-1 Uncoating and Reverse Transcription Require eEF1A Binding to Surface-Exposed Acidic Residues of the Reverse Transcriptase Thumb Domain. |
| Q36702218 | HIV-1 matrix protein: a mysterious regulator of the viral life cycle |
| Q91632953 | IL-27 posttranslationally regulates Y-box binding protein-1 to inhibit HIV-1 replication in human CD4+ T cells |
| Q37945202 | Implications of the nucleocapsid and the microenvironment in retroviral reverse transcription. |
| Q39439240 | In vitro uncoating of HIV-1 cores |
| Q41956340 | Isolated HIV-1 core is active for reverse transcription. |
| Q37781304 | Quiescent T cells and HIV: an unresolved relationship |
| Q44949244 | Resistance of monocyte to HIV-1 infection is not due to uncoating defect |
| Q36346812 | Retroviral infection of non-dividing cells: old and new perspectives |
| Q40255729 | Reverse transcription complex: the key player of the early phase of HIV replication |
| Q34387732 | Revisiting HIV-1 uncoating |
| Q33826918 | Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core |
| Q38230956 | Roles of HIV-1 capsid in viral replication and immune evasion |
| Q40290311 | Saturation of TRIM5 alpha-mediated restriction of HIV-1 infection depends on the stability of the incoming viral capsid |
| Q39362257 | Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects |
| Q24547409 | Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor |
| Q37410802 | Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. |
| Q37979697 | Targets for inhibition of HIV replication: entry, enzyme action, release and maturation |
| Q33511958 | The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells |
| Q40228456 | The effect of capsid mutations on HIV-1 uncoating |
| Q36156531 | The trinity of the cortical actin in the initiation of HIV-1 infection |
| Q39696042 | Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. |
| Q40619175 | VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability. |
Search more.